FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2260644877> ?p ?o ?g. }

• W2260644877 endingPage "e0004329" @default.
• W2260644877 startingPage "e0004329" @default.
• W2260644877 abstract "The Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) has launched several large-scale trials to determine the best strategies for gaining and sustaining control of schistosomiasis and transitioning toward elimination. In Côte d'Ivoire, a 5-year cluster-randomized trial is being implemented in 75 schools to sustain the control of schistosomiasis mansoni. We report Schistosoma mansoni infection levels in children one year after the initial school-based treatment (SBT) with praziquantel and compare with baseline results to determine the effect of the intervention.The baseline cross-sectional survey was conducted in late 2011/early 2012 and the first follow-up in May 2013. Three consecutive stool samples were collected from 9- to 12-year-old children in 75 schools at baseline and 50 schools at follow-up. Stool samples were subjected to duplicate Kato-Katz thick smears. Directly observed treatment (DOT) coverage of the SBT was assessed and the prevalence and intensity of S. mansoni infection compared between baseline and follow-up.The S. mansoni prevalence in the 75 schools surveyed at baseline was 22.1% (95% confidence interval (CI): 19.5-24.4%). The DOT coverage was 84.2%. In the 50 schools surveyed at baseline and one year after treatment, the overall prevalence of S. mansoni infection decreased significantly from 19.7% (95% CI: 18.5-20.8%) to 12.8% (95% CI: 11.9-13.8%), while the arithmetic mean S. mansoni eggs per gram of stool (EPG) among infected children slightly increased from 92.2 EPG (95% CI: 79.2-105.3 EPG) to 109.3 EPG (95% CI: 82.7-135.9 EPG). In two of the 50 schools, the prevalence increased significantly, despite a DOT coverage of >75%.One year after the initial SBT, the S. mansoni prevalence had decreased. Despite this positive trend, an increase was observed in some schools. Moreover, the infection intensity among S. mansoni-infected children was slightly higher at the 1-year follow-up compared to the baseline situation. Our results emphasize the heterogeneity of transmission dynamics and provide a benchmark for the future yearly follow-up surveys of this multi-year SCORE intervention study." @default.
• W2260644877 created "2016-06-24" @default.
• W2260644877 creator A5015991419 @default.
• W2260644877 creator A5022977016 @default.
• W2260644877 creator A5026901267 @default.
• W2260644877 creator A5031012479 @default.
• W2260644877 creator A5034376809 @default.
• W2260644877 creator A5036575912 @default.
• W2260644877 creator A5038182993 @default.
• W2260644877 creator A5045039770 @default.
• W2260644877 creator A5057810966 @default.
• W2260644877 creator A5065024993 @default.
• W2260644877 creator A5066637855 @default.
• W2260644877 creator A5067569019 @default.
• W2260644877 date "2016-01-20" @default.
• W2260644877 modified "2023-10-17" @default.
• W2260644877 title "Sustaining Control of Schistosomiasis Mansoni in Western Côte d’Ivoire: Results from a SCORE Study, One Year after Initial Praziquantel Administration" @default.
• W2260644877 cites W1561881988 @default.
• W2260644877 cites W1593775074 @default.
• W2260644877 cites W1634173298 @default.
• W2260644877 cites W1660602417 @default.
• W2260644877 cites W1969388639 @default.
• W2260644877 cites W1976656705 @default.
• W2260644877 cites W2003156271 @default.
• W2260644877 cites W2004587190 @default.
• W2260644877 cites W2006300406 @default.
• W2260644877 cites W2008795540 @default.
• W2260644877 cites W2014817719 @default.
• W2260644877 cites W2037763920 @default.
• W2260644877 cites W2041870448 @default.
• W2260644877 cites W2043732668 @default.
• W2260644877 cites W2050251476 @default.
• W2260644877 cites W2050444479 @default.
• W2260644877 cites W2055620139 @default.
• W2260644877 cites W2060910409 @default.
• W2260644877 cites W2068331056 @default.
• W2260644877 cites W2070082247 @default.
• W2260644877 cites W2083258338 @default.
• W2260644877 cites W2087004542 @default.
• W2260644877 cites W2089228326 @default.
• W2260644877 cites W2092722755 @default.
• W2260644877 cites W2094315264 @default.
• W2260644877 cites W2099269010 @default.
• W2260644877 cites W2100629206 @default.
• W2260644877 cites W2138575532 @default.
• W2260644877 cites W2140079493 @default.
• W2260644877 cites W2142206096 @default.
• W2260644877 cites W2143391656 @default.
• W2260644877 cites W2158475431 @default.
• W2260644877 cites W2160079627 @default.
• W2260644877 cites W2160630945 @default.
• W2260644877 cites W2162812556 @default.
• W2260644877 cites W2167847771 @default.
• W2260644877 cites W2183253973 @default.
• W2260644877 cites W4211245225 @default.
• W2260644877 cites W4249468831 @default.
• W2260644877 cites W4299662206 @default.
• W2260644877 cites W4300576676 @default.
• W2260644877 cites W4301447901 @default.
• W2260644877 cites W4302419854 @default.
• W2260644877 doi "https://doi.org/10.1371/journal.pntd.0004329" @default.
• W2260644877 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4720284" @default.
• W2260644877 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26789749" @default.
• W2260644877 hasPublicationYear "2016" @default.
• W2260644877 type Work @default.
• W2260644877 sameAs 2260644877 @default.
• W2260644877 citedByCount "30" @default.
• W2260644877 countsByYear W22606448772016 @default.
• W2260644877 countsByYear W22606448772017 @default.
• W2260644877 countsByYear W22606448772018 @default.
• W2260644877 countsByYear W22606448772019 @default.
• W2260644877 countsByYear W22606448772020 @default.
• W2260644877 countsByYear W22606448772021 @default.
• W2260644877 countsByYear W22606448772022 @default.
• W2260644877 countsByYear W22606448772023 @default.
• W2260644877 crossrefType "journal-article" @default.
• W2260644877 hasAuthorship W2260644877A5015991419 @default.
• W2260644877 hasAuthorship W2260644877A5022977016 @default.
• W2260644877 hasAuthorship W2260644877A5026901267 @default.
• W2260644877 hasAuthorship W2260644877A5031012479 @default.
• W2260644877 hasAuthorship W2260644877A5034376809 @default.
• W2260644877 hasAuthorship W2260644877A5036575912 @default.
• W2260644877 hasAuthorship W2260644877A5038182993 @default.
• W2260644877 hasAuthorship W2260644877A5045039770 @default.
• W2260644877 hasAuthorship W2260644877A5057810966 @default.
• W2260644877 hasAuthorship W2260644877A5065024993 @default.
• W2260644877 hasAuthorship W2260644877A5066637855 @default.
• W2260644877 hasAuthorship W2260644877A5067569019 @default.
• W2260644877 hasBestOaLocation W22606448771 @default.
• W2260644877 hasConcept C126322002 @default.
• W2260644877 hasConcept C165901193 @default.
• W2260644877 hasConcept C168563851 @default.
• W2260644877 hasConcept C203014093 @default.
• W2260644877 hasConcept C2776026265 @default.
• W2260644877 hasConcept C2776225656 @default.
• W2260644877 hasConcept C2776246342 @default.
• W2260644877 hasConcept C2776863245 @default.
• W2260644877 hasConcept C2779134260 @default.

• next